Carregant...
Tumor suppressor maspin as a modulator of host immune response to cancer
Despite the promising clinical outcome, the primary challenge of the curative cancer immunotherapy is to overcome the dichotomy of the immune response: tumor-evoked immunostimulatory versus tumor-induced immunosuppressive. The goal needs to be two-fold, to re-establish sustainable antitumor-cancer i...
Guardat en:
| Publicat a: | Bosn J Basic Med Sci |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4690435/ https://ncbi.nlm.nih.gov/pubmed/26614844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17305/bjbms.2015.783 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|